Alcohol abuse is usually regarded as the most likely cause of elevated serum liver enzyme values in those attending for well population screening, but we have found increased body weight to be an important contributing factor. We have measured serum levels of alanine amino-transferase (ALT), aspartate aminotransferase (AST) and y-glutamyl transferase (GGT) in approximately 21 000 men attending for routine health screening, and related these to behavioural factors such as alcohol consumption, cigarette smoking, exercise level and obesity.
Alcohol abuse is usually regarded as the most likely cause of elevated serum liver enzyme values in those attending for well population screening, but we have found increased body weight to be an important contributing factor. We have measured serum levels of alanine amino-transferase (ALT), aspartate aminotransferase (AST) and y-glutamyl transferase (GGT) in approximately 21 000 men attending for routine health screening, and related these to behavioural factors such as alcohol consumption, cigarette smoking, exercise level and obesity.
The levels of all three enzymes were positively correlated with levels of alcohol consumption. Decreasing levels of physical activity were associated with increases in mean AL T and GGT levels. Cigarette smoking showed only a weak effect on AL T and AST, which became non-significant after multivariate statistical analysis, but increasing consumption of cigarettes was associated with increased mean levels of GGT. In contrast, all three enzymes showed marked increases in mean levels with increasing body mass index (BMI). The effect of obesity was particularly important in the case of ALT: the prevalence of increased ALT values in obese subjects (BMI~31 kg/m') was more than eight times that in those with normal weight (BMI~25 kg/m"), even after allowing for the confounding effect of alcohol consumption.
This study is concerned solely with male subjects, but we hope to extend the analysis to females in the near future.
An early description of raised serum liver enzyme levels in the well population came from the Transfusion-Transmitted Viruses Study, 1 in which raised levels of alanine aminotransferase (ALT) were associated with sub-clinical hepatitis. However, since that time many studies on blood donors have demonstrated that elevated AL T levels are associated with factors other than viral infection, and that as many as 60-80% of raised values may be due to non-viral causes.P Factors which have been identified as contributing to raised levels of serum liver enzymes include excessive alcohol consumption.s" drugs,2,6 hereditary factors 2 ,7.8 and obesity. 2-4,9.10 In particular, obesity appears to be an important correlate of raised enzyme levels. Several workers have demonstrated changes in liver function and morphology in morbidly obese patientsI 1-16 and a recent Japanese study'? has found adverse effects on liver function in subjects who were only moderately obese (30-50% overweight).
Alanine aminotransferase, aspartate aminotransferase (AST) and y-glutamyl transferase (GGT) are used routinely for assessing liver function in subjects attending the BUPA Medical Centres for health screening. Alcohol abuse is usually regarded as the most likely cause of raised values of these enzymes. However, on the basis of our laboratory's conventional reference ranges (0-45 U/L for AL T; 0-50 U/L for AST; 0-80 U /L for GGT) we found that as many as 7% of the total male population, and almost 6% of teetotallers, were being classified as having 'abnormal' liver enzymes. Clearly, factors other than alcohol were involved. We therefore set out firstly to reassess the reference ranges for liver enzymes, and secondly to examine the relationships between serum levels of these enzymes and potentially modifiable factors such as alcohol consumption, cigarette smoking, exercise level and obesity in our large series of ostensibly healthy men.
Subjects and methods
The analysis was based on all male examinees attending the BUPA Medical Centre in London during 1987. Subjects are mostly from social classes I and II, self selected and almost always currently employed. About half attend as part of a company health scheme. Data on cigarette smoking, alcohol consumption and exercise level were obtained as part of a computerised medical history questionnaire. Age, height and weight were recorded at the time of examination, and body mass index (BMI) was calculated as weight/ (heightj'. Blood was taken into Vacutainers (Becton Dickinson, Vacutainer Systems Europe, B.P. 37-38241, Meycan, France) following a 6-12 h fast. Serum levels of alanine aminotransferase (AL T), aspartate aminotransferase (AST) and yglutamyl transferase (GGT) were determined on a Technicon SMAC II Autoanalyser by JSPS Ltd, London, according to the manufacturer's recommendations. Within-batch coefficients of variation for the analyses during the period of the study were 6·2% for ALT, 5·0% for AST and 5·3% for GGT. Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS/PC +) on a Tandon PCA30 personal computer.
Results
All three serum enzymes exhibited positively skewed distributions. This was particularly marked in the case ofGGT levels. Consequently, a logarithmic transformation was applied, and normal of 50 UjL for ALT, 40 UjL for AST, and viduals with log-transformed values lying outside 75 UjL for GGT. These values were subsequently the range (mean±3·5 SD) were excluded from found to be justified, using a modified version of subsequent analysis. the Merkouriou and Dix 'objective' method for Tables 1-5 show mean values ofALT, AST and the determination of reference ranges." Indi-GGT, and the percentage of raised values for ... each enzyme, by age, exercise level, alcohol consumption, cigarette smoking and body mass index. Within each of these tables, mean levels of each enzyme are compared by analysis of variance, and proportions of raised values by chisquared analysis. Figure I shows the mean value data graphically. ALT and GGT rise initially with age, then fall. AST shows no significant variation with age. All three enzymes show an increase in mean value with decreasing exercise level. Similarly, all three increase with increasing alcohol consumption-the effect being most marked in the case of GGT. Cigarette smoking has only a weak effect on ALT and AST, but increasing consumption is associated with increased mean levels of GGT, particularly in those smoking more than 20 cigarettes per day. All three enzymes show marked increases in mean levels with increasing body mass index. The independent contribution of each of these factors to the variation in enzyme levels was assessed by means of multiple linear regression analysis. Table 6 shows, for each enzyme, the factors which were significantly related to it, together with each corresponding partial correlation coefficient (i.e. the correlation between the enzyme level and the factor concerned, allowing for the effects of all the other factors). Body mass index shows the strongest correlation in all three cases. Table 7 shows the relative probabilities of having a raised enzyme level associated with lack of exercise, heavy drinking, heavy smoking and obesity. Thus, for example, those who regularly consume more than 6 units of alcohol per day are 5·3 times more likely to have a raised GGT level than those who are teetotal or drink only socially. For ALT lack ofexercise, heavy drinking and heavy smoking all carry approximately twice the probability of having a raised enzyme value. However, the relative probability associated with a body mass index:?: 31 kg/m! is much higher, at 9·03. In the case of AST the relative probabilities associated with inactivity and smoking are both 1-42. That associated with heavy drinking is higher, at 3·67 -but again, the highest relative probability (5-46) is associated with obesity. For GGT, the highest relative probability is associated with heavy drinking (5'29), followed by obesity at 4·16. In order to allow for the possibility that the obese group (BMI:?: 31 kg/m") might contain a disproportionately large percentage of heavy drinkers, heavy smokers or inactive individuals, the rela tive pro ba bilities of ha ving raised enzyme levels associated with obesity were re-calculated by comparing each of the subgroups of obese individuals who were active, who were teetotal or social drinkers, or who had never smoked cigarettes with the group of individuals with BMI:$; 25 kg/m". These 'adjusted' relative probabilities are shown in Table 8 . Adjusting for drinking reduces the relative probability from 5·46 to 3·99 for AST, and from 4·16 to 2·34 for GGT. However, for ALT adjusting for the other factors has little effect on the relative probability associated with obesity.
Discussion

Age
Exercise Alcohol Cigarettes 8MI
ALT -0,122 -0'082 0·076 AST 0'023 0·124 GGT -0,060 0·199 0·038 0·347 0·184 0·223
Our pattern of mean ALT levels by age is similar to that found by Kahn et al.' who showed that ALT peaked around age 35 in males, and then declined. Siest et a/. IS , in a study of over 12000 attendees at a health screening clinic, also found a similar age relationship, and suggested that transaminase levels may be related to muscle mass, as they found a direct correlation between AL T and body weight. We found a negative association between level of exercise taken and each of the three enzymes. Lack of exercise was associated with a significantly elevated prevalence of raised enzyme levels in each case -although this was marginal in the case of AST. This is in contrast to the findings of Polesky et a/.,6 who found in a study of 3400 blood donors that the level ofphysical activity did not differ between those with normal and those with high AL T levels.
We also found an increased relative probability of raised values associated with smoking more than 20 cigarettes/day. Again, this was marginal in the case of AST. This association does not appear to have been reported before.
The effects of alcohol on levels ofliver enzymes are well documented-< 19-24, and our findings of increasing enzyme levels with increasing alcohol consumption come as no surprise. What is of interest, however, is the magnitude of the effect associated with heavy drinking, relative to those associated with the other factors. For GGT, which is highly sensitive to alcohol consumption, this factor shows the highestrelative probability of raised values -although that for BMI is only marginally smaller, and the 95% confidence intervals overlap. However, the relative probability for BMI is greatly reduced when the analysis is restricted to teetotalers and social drinkerssuggesting that alcohol is the most important factor in the determination of GGT levels in our sample. For AST and ALT, the relative probabilities associated with obesity are greater than those associated with heavy drinking, even after adjusting the BMI figures to allow for the effects of alcohol consumption. This is especially marked in the case of ALT, where obesity carries a nine-fold relative probability, compared with a two-fold one for alcohol.
In a recent study of 1742 Scottish blood donors, Gillon et al? found that, out of 33 donors with raised AL T levels, 26 exceeded their ideal body weight by more than 10%, and 15 by more than 20%. However, they had no control group with which to compare these figures, and they stressed the importance of the 'elucidation of the apparent relationship between body weight and ALT level'. Similarly, the study of Friedman et al" also suffered from the lack of a control group. In a NIH study where a control group was available.' 30% of donors with raised ALT levels were found to be obese (> 130% of upper limit of ideal weight), compared to 6% of donors with a normal ALT. The corresponding figures in our study were 16·2% and 3·5%. Both studies thus yield a five-fold prevalence of obesity in subjects with raised ALT levels compared to those with normal levels.
A study of 4613 male employees from two companies in the Chiba area of Japan," reported significantly higher mean levels of ALT, AST and GGT in moderately obese subjects (30-50% overweight) compared with non-obese subjects. This remained true when the analysis was restricted to non-drinkers, but amongst drinkers the difference between obese and non-obese groups was significant only in the case of ALT. Twentyfour per cent of non-drinkers with moderate obesity had raised ALT levels, compared to 5·2% of non-obese non-drinkers-giving a relative probability ofa raised value of4·6. On the basis of computed tomography (CT) scan results, the authors concluded that the most likely cause of the abnormal liver test results was fatty change due to moderate obesity, and they urged that 'the physician should be aware of the high incidence of hepatic steatosis in non-drinking mildly or moderately obese subjects when seeing such a patient'. In a previous study (data unpublished) linking the results of CT liver scans to reported alcohol consumption and other factors, we have found that a high body mass index was associated with less dense liver scans-implying a fatty infiltration of the liver, which could in turn give rise to elevated enzyme levels. In another blood donor study, Sampliner et al,' performed needle biopsies on the livers of nine donors with persistently raised levels of ALT, and found prominent fatty vacuolisation of parenchymal cells in seven of these subjects.
Andersen et al:", in a study of 61 morbidly obese individuals, found fatty change in the livers of 85% of subjects, and also concluded that the degree of obesity was related to the degree offatty change. This prevalence figure is comparable with those from other studies". They also found a significant increase in serum AST levels in those with moderate or severe fatty change. In contrast, Manes et a/. 16 found an increase in AST activity only in those with marked hepatic steatosis.
The most important finding in the present study is the confirmation of the role of obesity in the elevation of serum liver enzyme levels, especially ALT. A body mass index of 31 kg/m! or greater occurred in 4·2% of our population, and 19·6% of these subjects had significantly raised ALT levels. Obese subjects with raised enzyme levels should be made aware of this relationship, and encouraged to reduce their weight accordingly. Likewise, physicians should bear this relationship in mind when interpreting the results of liver enzyme tests in obese patients.
